preloader

CELL THERAPY FOR TYPE 1 DIABETES IN MALAYSIA

Unlocking the Potential of Cell-based Therapies for You
CELL THERAPY FOR TYPE 1 DIABETES IN MALAYSIA

A pioneer in cell therapy for type 1 diabetes, Cyrona Cell's broad and leading cell therapy expertise has transformed the lives of many individuals living with multiple different health conditions.

How Can Cell Therapy Help You?

Cyrona Cell uses Wharton’s Jelly mesenchymal cells that have been derived from infant umbilical cords as they can:

  • Identify and migrate to sites of injury 
  • Encourage your existing cells to self-repair and adapt
  • Modulate your immune system to prevent it from targeting your remaining β-cells
  • Decrease inflammation to enable the body to heal
  • Protect and prevent the remaining β-cells from dying
  • Increase β-cell function
  • Transform into β-cells
  • Decrease dependence on injectable diabetes medications
  • Regulate blood sugar levels

 

Cellular Therapy: A Transformative Healthcare Solution

As type 1 diabetes is an autoimmune disease, the aim of cell therapy is to preserve what pancreatic β-cell function remains, repair and regenerate areas of damage, and to prevent the immune system from targeting the remaining β-cells in order to enable the body to resume regulating blood sugar levels and heal.

Scientifically-Proven Results

Year

University/Centre

Cohort Size

Study Duration

Results

2013

Qingdao University, China

29

21 months

Significantly improved blood sugar levels

2016

University of Miami, US, and Xiamen University, China

21

12 months

105.7% increase in C-peptide levels, 49.3% increase in insulin production, 12.6% decrease in HbA1c readings, 24.4% decrease in fasting blood sugar levels, and 29.9% lower reliance on daily diabetes injections and medications

2017

National Yang Ming University, China

   

Improved C-peptide,  insulin levels and glucose tolerance

2018

University of Perugia, Italy

 

216 days

Full and sustained hyperglycaemic remission

 

Why is Cyrona Cell the Right Choice for You?

Achieving high standards in our work is of paramount importance to us. As such, we only produce and use premium grade passage 1 (P1) and passage 2 (P2) Wharton’s Jelly mesenchymal stem cells (wjMSCs) in all our therapy programmes. These cellular products have also been thoroughly screened and analyzed in accordance with the requirements of The International Society for Cellular Therapy prior to use.

We also use the latest in cellular research and technologies to tailor our therapy programmes according to the needs of the individual. Furthermore, our microbiology and clinical team as well as our extensively experienced board-certified physicians are geared towards your safety and wellbeing.

 

 

More than 1000 people are choosing Cyrona Health

 

Start the Journey towards the Best Version of Yourself Today

All our therapy programmes are conducted using premium grade P1 and P2 wjMSCs and by board-certified experienced specialists. All patients are also provided with pre-transfusion analysis reports of any and all cellular and supplementary products used during treatment.

International patients will be provided with airport transfer services and accommodations as well as in-city transportation to and from every therapy session.

 

How Do We Proceed?

As no two people are alike, our specialists review each patient’s medical reports before developing the best treatment protocol to address their unique needs. Therefore, before speaking to one of our Customer Service Representatives, it is best to have the following handy:

  • Imaging results (MRI scan / CT scan / X-Ray)
  • Hematology reports (HbA1c blood test)
  • Medical evaluation reports
  • Pictures or videos of the patient (if applicable)

 

Our Facilities

Download a complimentary eBook about Type 1 Diabetes

Download our eBook and receive our weekly in-depth and exclusive newsletter about Type 1 Diabetes.

CELL THERAPY FOR TYPE 1 DIABETES IN MALAYSIA eBook